Impairment of pulmonary function is an independent risk factor for atrial fibrillation: The takahata study

International Journal of Medical Sciences

Volumn 8, Issue 7, 2011, Pages 514-522

  Shibata, Yoko ^a   Watanabe, Tetsu ^a   Osaka, Daisuke ^a   Abe, Shuichi ^a   Inoue, Sumito ^a   Tokairin, Yoshikane ^a   Igarashi, Akira ^a   Yamauchi, Keiko ^a   Kimura, Tomomi ^a   Kishi, Hiroyuki ^a   Aida, Yasuko ^a   Nunomiya, Keiko ^a   Nemoto, Takako ^a   Sato, Masamichi ^a   Konta, Tsuneo ^a   Kawata, Sumio ^a   Kato, Takeo ^a   Kayama, Takamasa ^a   Kubota, Isao ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; General population; Pulmonary function

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; HEART ATRIUM FIBRILLATION; HUMAN; INDEPENDENT VARIABLE; JAPAN; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RESPIRATORY AIRFLOW; RISK FACTOR; SPIROMETRY; STUDY DESIGN;

EID: 80054734767     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8.514     Document Type: Article

References (38)

1. Yao H, Rahman I. Current concepts on the role of inflammation in COPD and lung cancer. Curr Opin Pharmacol. 2009; 9: 375-83.
2. [Internet] Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org/
3. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: The Nippon COPD Epidemiology Study. Respirology. 2004; 9: 458-65.
4. Fabbri LM, Rabe KF. From COPD to chronic systemic inflam-matory syndrome? Lancet. 2007; 370: 797-9.
5. Igarashi A, Shibata Y, Yamauchi K, et al. Gly80ser polymor-phism of phospholipase A2-IID is associated with cytokine in-ducibility in A549 cells. Respiration. 2009; 78: 312-21.
6. Takabatake N, Sata M, Abe S, et al. Impaired systemic cell-mediated immunity and increased susceptibility to acute respiratory tract infections in patients with COPD. Respir Med. 2005; 99: 485-92.
7. Takabatake N, Shibata Y, Abe S, et al. A single nucleotide polymorphism in the CCL1 gene predicts acute exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 174: 875-85.
8. Falk JA, Kadiev S, Criner GJ, et al. Cardiac disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008; 5: 543-8.
9. Valli N, Gobinet A, Bordenave L. Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. J Lab Clin Med. 1999; 134: 437-44.
10. Inoue Y, Kawayama T, Iwanaga T, et al. High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonale. Intern Med. 2009; 48: 503-12.
11. Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010;362: 217-27.
12. Andrawes WF, Bussy C, Belmin J. Prevention of cardiovascular events in elderly people. Drugs Aging. 2005; 22: 859-76.
13. Aronow WS. Heart disease and aging. Med Clin North Am. 2006; 90: 849-62.
14. Inoue H, Fujiki A, Origasa H, et al. Prevalence of atrial fibrilla-tion in the general population of Japan: An analysis based on periodic health examination. Int J Cardiol. 2009; 137: 102-7.
15. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001; 104: 2886-91.
16. Amar D, Zhang H, Leung DH, et al. Older age is the strongest predictor of postoperative atrial fibrillation. Anesthesiology. 2002; 96: 352-6.
17. You RX, McNeil JJ, Farish SJ, et al. The influence of age on atrial fibrillation as a risk factor for stroke. Clin Exp Neurol. 1991; 28: 37-42.
18. Naccarelli GV, Hynes BJ, Wolbrette DL, et al. Atrial fibrillation in heart failure: Prognostic significance and management. J Cardiovasc Electrophysiol. 2003; 14: S281-6.
19. Alpert JS, Petersen P, Godtfredsen J. Atrial fibrillation: Natural history, complications, and management. Annu Rev Med. 1988; 39: 41-52.
20. Tsang TS, Barnes ME, Miyasaka Y, et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrilla-tion: A longitudinal cohort study of 21 years. Eur Heart J. 2008; 29: 2227-33.
21. Heeringa J, Kors JA, Hofman A, et al. Cigarette smoking and risk of atrial fibrillation: The Rotterdam study. Am Heart J. 2008; 156: 1163-9.
22. Tuan TC, Chang SL, Tai CT, et al. Impairment of the atrial substrates by chronic cigarette smoking in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2008; 19: 259-65.
23. Gramley F, Lorenzen J, Jedamzik B, et al. Atrial fibrillation is associated with cardiac hypoxia. Cardiovasc Pathol. 2010; 19: 102-11.
24. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The fram-ingham heart study. JAMA. 1994; 271: 840-4.
25. Buch P, Friberg J, Scharling H, et al. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J. 2003; 21: 1012-6.
26. Stewart S, Hart CL, Hole DJ, et al. Population prevalence, inci-dence, and predictors of atrial fibrillation in the Ren-frew/Paisley Study. Heart. 2001; 86: 516-21.
27. Osaka D, Shibata Y, Abe S, et al. Relationship between habit of cigarette smoking and airflow limitation in healthy Japanese individuals: The Takahata Study. Intern Med. 2010; 49: 1489-99.
28. Ryu JH, Krowka MJ, Pellikka PA, et al. Pulmonary hyperten-sion in patients with interstitial lung diseases. Mayo Clin Proc. 2007; 82: 342-50.
29. Konta T, Hao Z, Abiko H, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: The Takahata Study. Kidney Int. 2006; 70: 751-6.
30. The Committee of Pulmonary Physiology. JRS: Guidelines for pulmonary function tests: Spirometry, flow-volume curve, diffusion capacity of the lung. Tokyo, 2004.
31. Kishi H, Shibata Y, Osaka D, et al. FEV6 and FEV1/FEV6 in Japanese participants of the community-based annual health check: The Takahata Study. Intern Med. 2011; 50: 87-93.
32. Hsieh BP, Pham MX, Froelicher VF. Prognostic value of elec-trocardiographic criteria for left ventricular hypertrophy. Am Heart J. 2005; 150: 161-7.
33. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The sleep heart health study. Am J Respir Crit Care Med. 2006; 173: 910-6.
34. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmo-nary veins. N Engl J Med. 1998; 339: 659-66.
35. Kang H, Bae BS, Kim JH, et al. The relationship between chronic atrial fibrillation and reduced pulmonary function in cases of preserved left ventricular systolic function. Korean Circ J. 2009; 39: 372-7.
36. Higashimoto Y, Yamagata Y, Taya S, et al. Systemic inflamma-tion in chronic obstructive pulmonary disease and asthma: Similarities and differences. Respirology. 2008; 13: 128-33.
37. Fukutomi Y, Nakamura H, Kobayashi F, et al. Nationwide cross-sectional population-based study on the prevalences of asthma and asthma symptoms among Japanese adults. Int Arch Allergy Immunol. 2010;153: 280-7.
38. Ohno S, Nakaya T, Bando M, et al. [Nationwide epidemiologi-cal survey of patients with idiopathic interstitial pneumonias using clinical personal records]. Nihon Kokyuki Gakkai Zasshi. 2007; 45: 759-65.